SMT201600125B - Vaccini e agenti terapeutici contro gas combinati - Google Patents

Vaccini e agenti terapeutici contro gas combinati

Info

Publication number
SMT201600125B
SMT201600125B SM201600125T SM201600125T SMT201600125B SM T201600125 B SMT201600125 B SM T201600125B SM 201600125 T SM201600125 T SM 201600125T SM 201600125 T SM201600125 T SM 201600125T SM T201600125 B SMT201600125 B SM T201600125B
Authority
SM
San Marino
Prior art keywords
vaccines
therapeutic agents
agents against
combined gas
against combined
Prior art date
Application number
SM201600125T
Other languages
English (en)
Italian (it)
Inventor
Andrea Manetti
Sabrina Capo
Giuliano Bensi
Guido Grandi
Y Ros Imma Margarit
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of SMT201600125B publication Critical patent/SMT201600125B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201600125T 2008-09-17 2016-04-29 Vaccini e agenti terapeutici contro gas combinati SMT201600125B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9755108P 2008-09-17 2008-09-17
PCT/IB2009/006949 WO2010076618A1 (en) 2008-09-17 2009-09-17 Combination gas vaccines and therapeutics

Publications (1)

Publication Number Publication Date
SMT201600125B true SMT201600125B (it) 2016-07-01

Family

ID=41508998

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600125T SMT201600125B (it) 2008-09-17 2016-04-29 Vaccini e agenti terapeutici contro gas combinati

Country Status (18)

Country Link
US (2) US20100136041A1 (https=)
EP (1) EP2344523B1 (https=)
JP (2) JP5680536B2 (https=)
CN (1) CN102356090B (https=)
AU (1) AU2009334428B2 (https=)
BR (1) BRPI0919236A8 (https=)
CA (1) CA2737453A1 (https=)
DK (1) DK2344523T3 (https=)
ES (1) ES2566740T3 (https=)
HR (1) HRP20160306T1 (https=)
HU (1) HUE027618T2 (https=)
MX (1) MX2011002760A (https=)
NZ (1) NZ591633A (https=)
PL (1) PL2344523T3 (https=)
SI (1) SI2344523T1 (https=)
SM (1) SMT201600125B (https=)
WO (1) WO2010076618A1 (https=)
ZA (1) ZA201102005B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
HUE034251T2 (en) * 2009-10-30 2018-02-28 Glaxosmithkline Biologicals Sa Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
CN103239734B (zh) * 2012-02-10 2016-02-24 北京艾棣维欣生物技术有限公司 用于预防和/或治疗呼吸道合胞病毒感染的疫苗
GB201206366D0 (en) * 2012-04-11 2012-05-23 Absynth Biologics Ltd Bacterial vaccine
JP6283674B2 (ja) * 2012-09-18 2018-02-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 外膜小胞
KR102730367B1 (ko) * 2014-04-15 2024-11-15 그리피스 유니버시티 그룹 a 스트렙토코쿠스 백신
BE1022553A1 (fr) * 2014-05-07 2016-05-31 Glaxosmithkline Biologicals Sa Mutants de spy0269
US10329601B2 (en) * 2015-12-28 2019-06-25 Ionian Technologies, Inc. Nicking and extension amplification reaction (NEAR) of Streptococcus species
CN112442472B (zh) * 2020-11-30 2023-05-26 四川大学华西医院 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法
JP7601913B2 (ja) * 2021-01-19 2024-12-17 デンカ株式会社 タンパク質、溶血性連鎖球菌ワクチン、ｄｎａ、ベクター、形質転換体、タンパク質を製造する方法、バキュロウイルス、アグロバクテリウム、ラテックス粒子、キット及び抗ストレプトリジンｏ抗体の測定方法
GB202215414D0 (en) 2022-10-18 2022-11-30 Glaxosmithkline Biologicals Sa Vaccine
CN116875520B (zh) * 2023-07-12 2024-06-14 吉林农业大学 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用
CN120005039B (zh) * 2025-01-10 2025-12-19 遵义医科大学珠海校区 HtsA-SLOdm融合蛋白及其在制备A族链球菌疫苗中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827038D0 (en) * 1988-11-18 1988-12-21 Kehoe M Streptolysin o antigens & uses
US5866135A (en) * 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
ES2505695T3 (es) * 2003-07-31 2014-10-10 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunógenas para Streptococcus pyogenes
US7838010B2 (en) * 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
CA2668018A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
KR101621837B1 (ko) * 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
EP2537857B1 (en) * 2007-12-21 2017-01-18 GlaxoSmithKline Biologicals SA Mutant forms of streptolysin O

Also Published As

Publication number Publication date
CN102356090B (zh) 2016-01-20
JP5680536B2 (ja) 2015-03-04
AU2009334428A1 (en) 2010-07-08
HRP20160306T1 (hr) 2016-04-22
EP2344523B1 (en) 2016-02-10
SI2344523T1 (sl) 2016-06-30
BRPI0919236A2 (pt) 2015-12-15
NZ591633A (en) 2012-10-26
US20100136041A1 (en) 2010-06-03
WO2010076618A1 (en) 2010-07-08
BRPI0919236A8 (pt) 2023-01-31
MX2011002760A (es) 2011-06-16
CA2737453A1 (en) 2010-07-08
JP2012502969A (ja) 2012-02-02
AU2009334428B2 (en) 2014-02-20
JP2015038156A (ja) 2015-02-26
HUE027618T2 (en) 2016-11-28
DK2344523T3 (da) 2016-04-18
PL2344523T3 (pl) 2016-09-30
CN102356090A (zh) 2012-02-15
US20150132337A1 (en) 2015-05-14
ZA201102005B (en) 2016-09-28
EP2344523A1 (en) 2011-07-20
ES2566740T3 (es) 2016-04-15

Similar Documents

Publication Publication Date Title
SMT201600125B (it) Vaccini e agenti terapeutici contro gas combinati
LTPA2018006I1 (lt) Pakeistųjų oksazolidinonų kombinuota terapija
IL256268B (en) Vaccine nanotechnology
BRPI0916931A2 (pt) agentes terapêuticos
BRPI0909770A2 (pt) Vacina, e, kit
CR10571A (es) Vacuna virica recombinante
ATE450271T1 (de) Impfstoff
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
EP2293813A4 (en) NANO EMULSION VACCINES
EP2320045A4 (en) APPARATUS FOR TREATING EXHAUST GAS
DK2114993T3 (da) Vaccine
BRPI0917205A2 (pt) vacina polivalente
DK2144905T3 (da) Terapeutiske midler
DK2367717T3 (da) Overtryksmikroboblegenerator
FI20090134A0 (fi) Hissijärjestely ja menetelmä
EP2125500A4 (en) HIV COMBINED VACCINE AND METHOD OF PRIMO VACCINATION / REMINDER
BRPI0818598A2 (pt) agentes terapêuticos - 802
DK2422810T3 (da) Influenzavaccine
SMT201600041B (it) Agenti terapeutici 713
DK2090318T3 (da) Profylaktisk tuberkulosevaccine
DK2293846T3 (da) Depsipeptider og deres terapeutiske anvendelse
BRPI0921578A2 (pt) vacinas unitemporais
DK2393561T3 (da) Bærbar åndedrætsregulator
EP2309854A4 (en) ACCELERATED THERAPY:
FI20085531A0 (fi) Ilmankäsittelylaite